Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan
Source: Streetwise Reports  (1/6/20)
aTyr Pharma's shares traded 45% higher today after the firm reported that it had entered into a collaboration agreement with Kyorin Pharmaceutical for development and commercialization of its ATYR1923 drug in Japan. More >

Precipitate Gold Prepares to Drill Next to Pueblo Viejo
Source: Bob Moriarty for Streetwise Reports  (1/6/20)
Bob Moriarty of 321gold discusses the highly anticipated drill program at the Pueblo Grande property. More >

Technical Analyst: Gold at Resistance Level
Source: Clive Maund for Streetwise Reports  (1/6/20)
Technical analyst Clive Maund discusses the effects of geopolitics on the price of gold. More >

Biopharma's Migraine Phase 3 Trial Results 'Robust,' 'Impressive'
Source: Streetwise Reports  (1/3/20)
These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. More >

Clinical Program Started for Agitation with Schizophrenia, Bipolar Disorder
Source: Streetwise Reports  (1/3/20)
The design of and an opinion on the included studies are provided in an H.C. Wainwright & Co. report. More >

Biopharma Releases Topline Results from Psoriasis Trial
Source: Streetwise Reports  (1/3/20)
The company, however, will continue to advance the same therapeutic in two other diseases. More >

Oil Encountered in Offshore Guyana Well Positive for Adjacent Explorer
Source: Streetwise Reports  (1/3/20)
The result and what it means for a neighboring energy firm are provided in a Pareto Securities report. More >

Explorer Acquires District Scale-Sized Project in Ontario
Source: Streetwise Reports  (1/3/20)
With sufficient funds in place, the Vancouver-based company intends to start exploring the property this year. More >

Leap Therapeutics Lunges Forward on $132M Licensing Deal and $27M Equity Raise
Source: Streetwise Reports  (1/3/20)
Shares of Leap Therapeutics jumped 60% after the company reported that it signed an exclusive option and license agreement for its immuno-oncology drug DKN-01 with BeiGene in the Asia Pacific region excluding Japan. The firm also secured an additional $27 million in equity financing from BeiGene and two other investment groups. More >

Gold Producer to Sell Interest in Founding Asset
Source: Streetwise Reports  (1/2/20)
The transaction is briefly reviewed and assessed in a BMO Capital Markets report. More >

Hi-yo Silver, Away!
Source: Rick Mills for Streetwise Reports  (1/2/20)
Rick Mills of Ahead of the Herd breaks down the investment thesis behind his belief silver prices are poised to gallop ahead. More >

Precious Metals Miner Announces $10 Million Offtake Prepayment
Source: Streetwise Reports  (1/2/20)
The agreement pertains to future gold-silver concentrate produced at the company's Mexican operations. More >

Explorer Closes Private Placement with Eric Sprott
Source: Streetwise Reports  (1/2/20)
The Canadian base and precious metals company will use the proceeds to explore its project in British Columbia. More >

TriStar Gold, Another Wits Lookalike in Brazil
Source: Bob Moriarty for Streetwise Reports  (1/2/20)
Bob Moriarty of 321gold discusses the similarities between this project and the Witwatersrand deposit in South Africa. More >

Pulmatrix's Licensing Deal with the JNJ Lung Cancer Initiative Sends Shares Up 100%
Source: Streetwise Reports  (1/2/20)
Pulmatrix's shares opened 90% higher today after the firm reported that it has signed a kinase inhibitor licensing agreement with the Lung Cancer Initiative at Johnson & Johnson. More >

Augmented Reality Firm Inks Deal with Weby Corp.
Source: Streetwise Reports  (1/2/20)
Accordingly, the tech company will provide its e-commerce platform. More >

Updated Resource Estimate Released for California Gold Project
Source: Streetwise Reports  (1/2/20)
Fieldwork is being done on the property to further determine its upside potential. More >

Firm Announces Contract to Supply Oil to Peru-Owned Company
Source: Streetwise Reports  (12/31/19)
It will produce the oil to be sold at its flagship asset in the Maranon Basin. More >

Copper Firm Recaps Encouraging Results from 2019 Exploration
Source: Streetwise Reports  (12/31/19)
The company's successes in this regard align with its aim to capitalize on its organic growth and land position. More >

Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device
Source: Streetwise Reports  (12/31/19)
Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina. More >

Beware the Stock Market
Source: Bob Moriarty for Streetwise Reports  (12/31/19)
Sector expert Bob Moriarty takes a look at drivers in the bull market and sees a bear in the wings. More >

Savara Shares Double After FDA Grants Breakthrough Therapy Status for aPAP Treatment
Source: Streetwise Reports  (12/30/19)
Shares of Savara opened nearly 140% higher today after the orphan lung disease company advised that the FDA has granted Breakthrough Therapy designation for the firm's Molgradex for treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP). More >

Basel III and Bailouts: What Do They Mean for the Markets?
Source: Maurice Jackson for Streetwise Reports  (12/30/19)
Maurice Jackson of Proven and Probable interviews Andy Schectman of Miles Franklin Precious Metals Investments about the implications of monetary policies being implemented by central banks worldwide, and about the state of the U.S. economy. More >

Gold Market Update: Metal Up, Dollar Down
Source: Clive Maund for Streetwise Reports  (12/30/19)
Technical expert Clive Maund charts the reasons the precious metals have entered a bull market. More >

Silver Market Update: A Bullish Setup in Place
Source: Clive Maund for Streetwise Reports  (12/30/19)
Technical analyst Clive Maund charts the end-of-the-year status of the silver market. More >